Overview

• Chief executive Peter Goldschmidt said the company is preparing an autumn offering in Frankfurt if conditions permit, with a formal announcement expected within days and October in view.
• A potential valuation around €10 billion would place the deal among Europe’s largest this year and make Stada a candidate for inclusion in the MDax.
• Proceeds are intended to reduce leverage, with management saying the IPO would roughly halve about €5.7 billion of acquisition-driven debt.
• Stada has set up a Dutch holding structure for the float, while keeping its operational headquarters in Bad Vilbel unchanged.
• Bain Capital and Cinven, which bought Stada for €5.3 billion in 2017 and took it private, have not disclosed how many shares they might sell, as the company reports mid‑single‑digit first‑half growth led by specialty medicines.